Molecular designing, crystal structure determination and in silico screening of copper(II) complexes bearing 8-hydroxyquinoline derivatives as anti-COVID-19

This publication has 23 references indexed in Scilit:

• Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
  Medical Hypotheses, 2020
• COVID-19 pathophysiology: A review
  Clinical Immunology, 2020
• The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
  Nature Microbiology, 2020
• In situ reactivity of electrochemically generated nitro radical anion on Ornidazole and its monomeric Cu(II) complex with nucleic acid bases and calf thymus DNA
  Inorganica Chimica Acta, 2020
• Current Drugs with Potential for Treatment of COVID-19: A Literature Review
  Journal of Pharmacy & Pharmaceutical Sciences, 2020
• Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action
  Malaria Journal, 2014
• The many “faces” of copper in medicine and treatment
  BioMetals, 2014
• Structural and some medicinal characteristics of the copper(II)–hydroxychloroquine complex
  Bioorganic & Medicinal Chemistry Letters, 2013
• Release studies from smart hydrogels as carriers for piroxicam and copper(II)–oxicam complexes as anti-inflammatory and anti-cancer drugs. X-ray structures of new copper(II)–piroxicam and –isoxicam complex molecules
  Journal of Inorganic Biochemistry, 2008
• Novel Copper(II) Complex ofN-Propyl-norfloxacin and 1,10-Phenanthroline with Enhanced Antileukemic and DNA Nuclease Activities
  Journal of Medicinal Chemistry, 2008